Varlilumab Is Safe and Active in Patients with Advanced Solid Tumors.
Sign Up to like & getrecommendations! Published in 2017 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-rw2017-089
Abstract: Varlilumab activates the CD27 pathway in T cells to promote antitumor activity in solid tumors. read more here.
Keywords: solid tumors; advanced solid; patients advanced; active patients ... See more keywords